IM
Immunicum
IMMU.ST·OMXStockholm SEFounded 200230 employees
Micro CapbiotechPublicOncology
Platform: Ilixadencel DCP
Market Cap
$0.03B
All Drugs
2
Clinical Trials
2
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (IMMU.ST)
Loading IMMU.ST stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Talatinib | IMM-7615 | Phase 2 | 1 | Aβ | DMDFSGS | ||
| IMM-6534 | IMM-6534 | Phase 1/2 | 1 | Nectin-4 | TTR AmyloidosisMDD |
SEC Filings & Financial Documents
SEC filings are not available for OMX-listed companies.
Immunicum trades on OMX (SE). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (1)